peptide sciences ghk-cu 50mg Research GHK-CU 50mg - Research Peptide

Its structure is a continuous escalation-then-maintenance arc: Initiation phase (weeks 14): 2.5 mg weekly

While clinical studies have explored its use in topical skincare and wound care, the 100mg formulation provides a high-concentration, cost-effective foundation for longitudinal studies, dose-response curves, and combination protocols particularly when paired with BPC-157 or TB-500

Researchers benefit from its reliable quality, high stability, and verified purity, making DSIP suitable for a variety of laboratory applications, including biochemical assays, peptide research, and neurophysiological studies

Freeze aliquots immediately after preparation

Critically, FOXO4-DRI treatment had no measurable effect on cell viability of non-senescent cells